X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19223) 19223
Magazine Article (173) 173
Newspaper Article (118) 118
Book Chapter (63) 63
Book / eBook (7) 7
Conference Proceeding (3) 3
Reference (3) 3
Book Review (2) 2
Dissertation (2) 2
Newsletter (2) 2
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17623) 17623
female (8944) 8944
adrenal cortex hormones - therapeutic use (8638) 8638
male (8240) 8240
adrenal cortex hormones - adverse effects (7863) 7863
adult (5736) 5736
middle aged (5033) 5033
adrenal cortex hormones - administration & dosage (4790) 4790
aged (3341) 3341
corticosteroids (3217) 3217
child (2779) 2779
treatment outcome (2674) 2674
adolescent (2532) 2532
animals (2390) 2390
risk factors (1936) 1936
asthma - drug therapy (1914) 1914
administration, inhalation (1586) 1586
medicine, general & internal (1515) 1515
drug therapy, combination (1487) 1487
retrospective studies (1402) 1402
time factors (1400) 1400
child, preschool (1380) 1380
immunosuppressive agents - therapeutic use (1371) 1371
asthma (1368) 1368
therapy (1366) 1366
pregnancy (1188) 1188
immunology (1182) 1182
care and treatment (1160) 1160
children (1122) 1122
pharmacology & pharmacy (1054) 1054
respiratory system (1054) 1054
steroids (1018) 1018
neurosciences (1002) 1002
drug therapy (983) 983
pediatrics (976) 976
medicine & public health (968) 968
surgery (963) 963
double-blind (944) 944
young adult (915) 915
dermatology (911) 911
research (909) 909
infant (889) 889
health aspects (883) 883
abridged index medicus (881) 881
allergy (873) 873
pituitary-adrenal axis (872) 872
endocrinology & metabolism (870) 870
stress (860) 860
management (857) 857
follow-up studies (845) 845
immunosuppressive agents - adverse effects (832) 832
analysis (831) 831
dose-response relationship, drug (796) 796
aged, 80 and over (792) 792
severity of illness index (792) 792
diagnosis (772) 772
infant, newborn (751) 751
randomized controlled trials as topic (742) 742
prospective studies (717) 717
rats (713) 713
prognosis (703) 703
risk (680) 680
internal medicine (678) 678
anti-inflammatory agents - therapeutic use (672) 672
glucocorticoids (660) 660
transplantation (659) 659
rheumatology (658) 658
drug administration schedule (656) 656
adrenal cortex hormones - pharmacology (620) 620
mortality (610) 610
administration, oral (609) 609
administration, topical (605) 605
chronic disease (599) 599
disease (588) 588
efficacy (586) 586
psychiatry (580) 580
diagnosis, differential (578) 578
inflammation (575) 575
inhaled corticosteroids (574) 574
pulmonary disease, chronic obstructive - drug therapy (562) 562
acute disease (527) 527
age factors (525) 525
gastroenterology & hepatology (522) 522
recurrence (522) 522
adrenal cortex hormones (517) 517
patients (510) 510
clinical neurology (509) 509
anti-bacterial agents - therapeutic use (502) 502
oncology (500) 500
double-blind method (499) 499
risk assessment (498) 498
anti-inflammatory agents - adverse effects (494) 494
disease progression (487) 487
dosage and administration (482) 482
hormones (477) 477
adrenal glands (474) 474
cohort studies (473) 473
bronchodilator agents - therapeutic use (471) 471
anti-asthmatic agents - therapeutic use (470) 470
cortisol (464) 464
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16723) 16723
French (951) 951
German (741) 741
Spanish (257) 257
Japanese (196) 196
Italian (185) 185
Russian (170) 170
Polish (120) 120
Dutch (76) 76
Chinese (52) 52
Portuguese (43) 43
Romanian (37) 37
Norwegian (35) 35
Danish (30) 30
Hungarian (29) 29
Czech (27) 27
Hebrew (26) 26
Finnish (18) 18
Bulgarian (15) 15
Swedish (13) 13
Croatian (8) 8
Ukrainian (8) 8
Turkish (6) 6
Serbian (5) 5
Korean (4) 4
Slovak (3) 3
Lithuanian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2018, Volume 141, Issue 1, pp. 110 - 116.e7
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 4, p. CD006545
.... This is an update of a Cochrane Review first published in 2011. Objectives To assess the effects of interventions for the management of infantile haemangiomas in children... 
Vascular birthmarks e.g infantile haemangiomas | Adrenal Cortex Hormones | Methylprednisolone | Photochemotherapy | topical steroids | lasers | Bleomycin | corticosteroids | Child health | systemic steroids | Propranolol | Hemangioma, Capillary | Prednisolone | Timolol | W. BIRTH MARKS AND DEVELOPMENTAL ABNORMALITIES OF THE SKIN | vincristine | Antineoplastic Agents | Radiotherapy | interferon | Remission Induction | Skin disorders | laser therapy | Randomized Controlled Trials as Topic | intralesional steroids | Skin Neoplasms | imiquimod | Adrenergic beta‐Antagonists | Lasers, Dye | Birthmarks | Skin | Medicine General & Introductory Medical Sciences | W6 Vascular malformations e.g. port‐wine stains | surgery | Antineoplastic Agents [therapeutic use] | Humans | Prednisolone [adverse effects; therapeutic use] | Child, Preschool | Infant | RANDOMIZED CONTROLLED-TRIAL | INTRALESIONAL BLEOMYCIN | MEDICINE, GENERAL & INTERNAL | PULSED DYE-LASER | Radiotherapy [methods] | TOPICAL PROPRANOLOL | Bleomycin [therapeutic use] | INTENSITY FOCUSED ULTRASOUND | TIMOLOL MALEATE 0.5-PERCENT | UNTREATED HEMANGIOMAS | SEQUENTIAL COMBINATION | RISK-FACTORS | Lasers, Dye [therapeutic use] | Remission Induction [methods] | Skin Neoplasms [therapy] | Adrenal Cortex Hormones [adverse effects; therapeutic use] | ORAL PROPRANOLOL | Hemangioma, Capillary [therapy] | Methylprednisolone [adverse effects; therapeutic use] | Photochemotherapy [methods] | Prednisolone - adverse effects | Methylprednisolone - therapeutic use | Skin Neoplasms - therapy | Hemangioma, Capillary - therapy | Photochemotherapy - methods | Timolol - administration & dosage | Methylprednisolone - adverse effects | Antineoplastic Agents - therapeutic use | Lasers, Dye - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Bleomycin - therapeutic use | Propranolol - administration & dosage | Radiotherapy - methods | Remission Induction - methods | Prednisolone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 6, p. CD003725
Background Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood. Untreated, this incurable disease, which has an X‐linked... 
Muscle Diseases | Pregnenediones | Glucocorticoids | Adrenal Cortex Hormones | Prednisone | Randomized Controlled Trials as Topic | Walking | Neurology | Duchenne muscular dystrophy | Child health | Quality of Life | Muscular dystrophies | Muscle disease | Muscular Dystrophy, Duchenne | Medicine General & Introductory Medical Sciences | Muscle Strength | Prednisolone | Corticosteroid treatment | AMERICAN ACADEMY | CONTROLLED-TRIAL | LOW-DOSAGE | Humans | Male | Adrenal Cortex Hormones [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [adverse effects; therapeutic use] | PREDNISONE TREATMENT | Prednisolone [therapeutic use] | Prednisone [therapeutic use] | DEFLAZACORT TREATMENT | GLYCOPROTEIN COMPLEX | DOUBLE-BLIND | Muscular Dystrophy, Duchenne [drug therapy] | MOLECULAR PATHOGENESIS | Pregnenediones [therapeutic use] | STEROID-THERAPY | LONG-TERM TREATMENT | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Muscular Dystrophy, Duchenne - drug therapy | Pregnenediones - administration & dosage | Adrenal Cortex Hormones - therapeutic use | Pregnenediones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Muscle Strength - drug effects | Prednisolone - therapeutic use | Glucocorticoids - adverse effects | Prednisone - therapeutic use | Adrenal Cortex Hormones - administration & dosage
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2016, Issue 1, p. CD009878
Background Inhaled corticosteroids (ICS) are the first‐line treatment for children with persistent asthma. Their potential for growth suppression remains a... 
Pregnadienediols | Budesonide | Pregnenediones | Lungs & airways | Growth | Adrenal Cortex Hormones | Androstadienes | Administration, Inhalation | Anti‐Asthmatic Agents | Fluticasone | Asthma | Randomized Controlled Trials as Topic | Asthma (chronic): corticosteroids | Dose‐Response Relationship, Drug | Steroids, inhaled | Beclomethasone | Asthma (chronic) | Child health | Mometasone Furoate | Asthma, chronic ‐ pharmacotherapy | Growth Disorders | Medicine General & Introductory Medical Sciences | Corticosteroids (inhaled, oral or intranasal) | BUDESONIDE INHALATION SUSPENSION | ONCE-DAILY CICLESONIDE | MEDICINE, GENERAL & INTERNAL | FLUTICASONE PROPIONATE | COLLAGEN TURNOVER | IMPROVES LUNG-FUNCTION | LONG-TERM SAFETY | MOMETASONE FUROATE | BECLOMETHASONE DIPROPIONATE AEROSOL | EXHALED NITRIC-OXIDE | CHILDHOOD ASTHMA | Anti-Asthmatic Agents - adverse effects | Beclomethasone - administration & dosage | Growth Disorders - chemically induced | Humans | Pregnenediones - administration & dosage | Pregnadienediols - administration & dosage | Asthma - drug therapy | Pregnenediones - adverse effects | Dose-Response Relationship, Drug | Growth - drug effects | Adrenal Cortex Hormones - adverse effects | Androstadienes - administration & dosage | Pregnadienediols - adverse effects | Budesonide - adverse effects | Beclomethasone - adverse effects | Anti-Asthmatic Agents - administration & dosage | Budesonide - administration & dosage | Androstadienes - adverse effects | Child | Adrenal Cortex Hormones - administration & dosage
Journal Article